OxyContin's Troubling Launch

This chapter explores the deceptive marketing of OxyContin by Purdue Pharma, focusing on the misleading claims about its safety compared to morphine. It details the ethical issues, systemic failures, and the resulting opioid crisis driven by irresponsible prescribing and corporate influence in the medical community.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app